« Return to News | CROs/Service Providers

Covance Reports Jump in Fourth Quarter Revenue

Friday, February 8, 2008 01:55 PM

Princeton, N.J.-based CRO Covance reported a nearly 20% jump in fourth quarter net revenue to $411 million compared with $343 million in 2006. Net income was also impressive, $47 million, a 22% increase compared with the fourth quarter of 2006. Earnings per share were $0.72 in the quarter, up 21.8% compared with the fourth quarter of 2006. Fourth quarter revenues were split evenly between Covance’s early development and late-stage development business units.

Within the CRO’s early development services, its central lab business saw fourth quarter revenue increase by 11% and year-on-year revenue by 21%. Covance’s phase II-III business also saw revenue growth in excess of 20% both for the fourth quarter and the full year. For the full year 2007, Covance’s total revenues were $1.55 billion, up 15.4% compared with 2006. Full year operating income increased 18.3% to $229 million. Net income grew to $172 million in 2007, up 20.5%. Full year EPS was 265, up 20.5% over the year prior.

“These results topped our internal budget helping us drive at 21% growth in backlog to $2.7 billion and a strong net book-to-bill of 1.28:1 for the full year. Increasing levels of client satisfaction led to strong repeat work resulting in more than $500 million in net orders for the quarter and a 20.6% growth in our backlog to $2.7 billion,” said Joe Herring, chief executive officer of Covance.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.